Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects.
Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects.
复制标题
DOI:
10.1155/2021/8895376
复制
发表时间:
2021
期刊:
影响因子:
2.9
通讯作者:
Ibarra-Lara L
中科院分区:
文献类型:
--
作者:
Cortes-Lopez F;Sanchez-Mendoza A;Centurion D;Cervantes-Perez LG;Castrejon-Tellez V;Del Valle-Mondragon L;Soria-Castro E;Ramirez V;Sanchez-Lopez A;Pastelin-Hernandez G;Garcia-Niño WR;Sanchez-Aguilar M;Ibarra-Lara L
Lesions caused by high glucose (HG), hypoxia/reperfusion (H/R), and the coexistence of both conditions in cardiomyocytes are linked to an overproduction of reactive oxygen species (ROS), causing irreversible damage to macromolecules in the cardiomyocyte as well as its ultrastructure. Fenofibrate, a peroxisome proliferator-activated receptor alpha (PPARα) agonist, promotes beneficial activities counteracting cardiac injury. Therefore, the objective of this work was to determine the potential protective effect of fenofibrate in cardiomyocytes exposed to HG, H/R, and HG+H/R. Cardiomyocyte cultures were divided into four main groups: (1) control (CT), (2) HG (25 mM), (3) H/R, and (4) HG+H/R. Our results indicate that cell viability decreases in cardiomyocytes undergoing HG, H/R, and both conditions, while fenofibrate improves cell viability in every case. Fenofibrate also decreases ROS production as well as nicotinamide adenine dinucleotide phosphate oxidase (NADPH) subunit expression. Regarding the antioxidant defense, superoxide dismutase (SOD Cu2+/Zn2+ and SOD Mn2+), catalase, and the antioxidant capacity were decreased in HG, H/R, and HG+H/R-exposed cardiomyocytes, while fenofibrate increased those parameters. The expression of nuclear factor erythroid 2-related factor 2 (Nrf2) increased significantly in treated cells, while pathologies increased the expression of its inhibitor Keap1. Oxidative stress-induced mitochondrial damage was lower in fenofibrate-exposed cardiomyocytes. Endothelial nitric oxide synthase was also favored in cardiomyocytes treated with fenofibrate. Our results suggest that fenofibrate preserves the antioxidant status and the ultrastructure in cardiomyocytes undergoing HG, H/R, and HG+H/R preventing damage to essential macromolecules involved in the proper functioning of the cardiomyocyte.
登录
查看更多内容
DOI:
10.1056/nejmoa1001288
发表时间:
2010-07-15
期刊:
The New England journal of medicine
影响因子:
--
作者:
ACCORD Study Group;ACCORD Eye Study Group;Chew EY;Ambrosius WT;Davis MD;Danis RP;Gangaputra S;Greven CM;Hubbard L;Esser BA;Lovato JF;Perdue LH;Goff DC Jr;Cushman WC;Ginsberg HN;Elam MB;Genuth S;Gerstein HC;Schubart U;Fine LJ
通讯作者:
Fine LJ
DOI:
10.3390/molecules22010031
发表时间:
2016-12-28
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
作者:
Ibarra-Lara L;Sánchez-Aguilar M;Sánchez-Mendoza A;Del Valle-Mondragón L;Soria-Castro E;Carreón-Torres E;Díaz-Díaz E;Vázquez-Meza H;Guarner-Lans V;Rubio-Ruiz ME
通讯作者:
Rubio-Ruiz ME
影响因子:
3
作者:
Ibarra-Lara, Luz;Hong, Enrique;Sanchez-Mendoza, Alicia
通讯作者:
Sanchez-Mendoza, Alicia
影响因子:
5.4
作者:
Biddlestone J;Bandarra D;Rocha S
通讯作者:
Rocha S
DOI:
10.1083/jcb.201102095
发表时间:
2011-07-11
期刊:
The Journal of cell biology
影响因子:
--
作者:
Finkel T
通讯作者:
Finkel T